| Skin and Soft Tissue Infection |
1 |
1 |
| Human Papillomavirus |
0 |
0.69 |
| Europe |
0 |
0.65 |
| Bacterial Vaginosis |
0 |
0.99 |
| Fungal Infection |
0 |
0.41 |
| Bacteria |
0 |
0.32 |
| Candidiasis |
0 |
0.27 |
| Healthcare and Medical Technology |
0 |
0.27 |
| Clinical Research |
0 |
0.22 |
| Maryland |
0 |
0.22 |
| Massachusetts |
0 |
0.22 |
| Sexually Transmitted Infection |
0 |
0.22 |
| Cervical Dysplasia |
0 |
0.15 |
| Antibiotics |
0 |
0.13 |
| Cervical Cancer |
0 |
0.13 |
| Pregnancy |
0 |
0.13 |
| Antifungal |
0 |
0.11 |
| Dysplasia |
0 |
0.11 |
| Epidemiology |
0 |
0.11 |
| Germany |
0 |
0.11 |
| Grant |
0 |
0.11 |
| Hospital |
0 |
0.11 |
| Papillomavirus |
0 |
0.11 |
| Spain |
0 |
0.11 |
| Vulvovaginal Candidiasis |
0 |
0.11 |